Trade Accuray - ARAY CFD
What is Accuray (ARAY)?
Accuray Incorporated is a global radiation oncology company that develops, manufactures, and sells innovative treatment solutions for cancer and other medical conditions. The company specializes in the design and production of advanced radiation therapy systems, including robotic radiosurgery and adaptive radiation therapy technologies. Its products aim to improve the precision and effectiveness of cancer treatments while minimizing damage to surrounding healthy tissues. Accuray's solutions are utilized by healthcare providers worldwide in hospitals and cancer treatment centers. The company focuses on integrating imaging, planning, and delivery systems to enhance treatment accuracy and patient outcomes. Accuray operates within the medical device industry and is involved in ongoing research and development to advance cancer treatment technologies. Its portfolio includes systems that support stereotactic radiosurgery and stereotactic body radiation therapy, addressing a range of tumor types and clinical indications. The company also provides related services and support to healthcare professionals using its technologies.
Accuray Stock Price Today: Live Overview
The price today is shaped by market activity, as Accuray stands at $0.418. Its price has ranged between $0.3722 and $0.4212 during the session, resulting in a daily movement of +4.1989%.
FAQ: Accuray (ARAY)
What is the current price of ARAY stock?
The current trading value stands at $0.418.
Does ARAY pay dividends?
Dividends are paid via cash distributions (if applicable).
Does ARAY have a formal corporate presence or regional headquarters in the UAE?
The company operates via partners and distributors in the UAE with no official regional office or subsidiary.
What is ARAY best known for?
Accuray is most famous for its advanced radiation oncology treatment systems.
What assets are typically shown together with ARAY?
Commonly shown alongside ARAY: BJ's Restaurants Inc, Budimex SA, Natural Gas Services Group Inc
Latest shares articles



